Atlas Trials

Locally Advanced or Metastatic HER2-Expressing Cancers

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Locally Advanced or Metastatic HER2-Expressing Cancers

RecordFirmDate
To Access the Safety and Effects of Intravenous Administration of VIR-5818 Alone and in Combination With Pembrolizumab in Adult Participants With Locally Advanced or Metastatic HER2-Expressing Cancers (NCT05356741)Vir Biotechnology, Inc.2022-04-13

Track Locally Advanced or Metastatic HER2-Expressing Cancers automatically

Every clearance here is in the API, with alerts when new ones post.